Search

Elastomeric Infusion Pump Market By Type Of Pump (Peristaltic pumps, Diaphragm pumps, Piston pumps); By Application Type (Pain management, Chemotherapy, Antibiotics); By End-User (Hospitals, Clinics, Home Healthcare Settings); By Product Type (Disposable, Reusable); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Market Analysis, Trends, Opportunity and Forecast, 2022-2032

Elastomeric Infusion Pump Market Insights

An elastomeric infusion pump may be a sort of medical device that delivers an endless flow of medication or fluid to a patient over a selected period of your time. It consists of a versatile elastomeric balloon or reservoir that's crammed with medication or fluid and attached to a delivery tube. The pump is meant to slowly release the medication or fluid at a continuing rate through the delivery tube and into the patient's body. Elastomeric infusion pumps are often used for patients who require long-term intravenous therapy, like chemotherapy, pain management, or antibiotic treatment, or also can be used for patients who require continuous fluid therapy, like hydration or nutrition.

One of the most advantages of elastomeric infusion pumps is their simplicity and simple use. they are doing not require any external power source or complicated programming, which makes them ideal to be used in home care settings or developing countries with limited resources. Additionally, they're often less costly than other sorts of infusion pumps and may be easily disposed of after use.


Elastomeric Infusion Pump Market Share and Size

The marketplace for elastomeric infusion pumps is predicted to grow within the coming years thanks to a variety of things, including an aging population, the increasing prevalence of chronic diseases, and therefore the growing demand for home healthcare services. The global elastomeric infusion pump market was valued at USD 610.8 million in 2022 and is predicted to succeed at USD 1.0 billion by 2032, growing at a CAGR of 5.2% during the forecast period of 2023-2032.

One of the key drivers of the elastomeric infusion pump market is the rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders. These conditions often require long-term intravenous therapy, which may be delivered more conveniently and cost-effectively through elastomeric infusion pumps.

There are a variety of companies that manufacture and sell elastomeric infusion pumps, including B. Braun Melsungen AG, Fresenius Kabi, and Terumo Corporation. These companies offer a variety of elastomeric infusion pumps with different features and capabilities, and they compete with market-supported factors like product quality, price, and customer service.


Elastomeric Infusion Pump Market Latest Trends

Here are some of the latest trends in the elastomeric infusion pump market:

  1. Development of smart pumps: Smart elastomeric infusion pumps are being developed with advanced features like wireless connectivity, remote monitoring, and data analytics. These pumps can provide real-time data on infusion rates, volume delivered, and other parameters, allowing healthcare providers to watch patients more closely and make more informed treatment decisions.
  2. Growing demand for home healthcare: There's a growing demand for home healthcare services, and this is often expected to drive the marketplace for elastomeric infusion pumps. As more patients receive treatment reception, the necessity for reliable, portable infusion pumps will increase.
  3. Growing demand in emerging markets: The elastomeric infusion pump market is seeing significant growth in emerging markets like Asia-Pacific and Latin America. this is often thanks to the increasing demand for home healthcare services in these regions, and also because of the growing prevalence of chronic diseases.
  4. The growing popularity of disposable pumps: Disposable elastomeric infusion pumps are getting increasingly popular thanks to their convenience and cost-effectiveness. These pumps eliminate the necessity for cleaning and maintenance and may be easily disposed of after use. As a result, they're being increasingly utilized in home healthcare settings.
  5. Increased specialization in patient safety: With patient safety being a top priority within the healthcare industry, there's an increased specialization in developing elastomeric infusion pumps which will minimize the danger of medication errors and other complications. This has led to the event of pumps with advanced features like flow control, occlusion alarms, and anti-siphon valves.
  6. Rising use of disposable pumps: There's a trend towards the utilization of disposable elastomeric infusion pumps, which may be less expensive and reduce the danger of infections. These pumps are typically single-use and are disposed of after a patient's treatment is complete.
  7. Use of elastomeric infusion pumps in veterinary medicine: Elastomeric infusion pumps aren't just utilized in human medicine, but also are gaining popularity in medicine. These pumps are getting used to deliver fluids and medications to animals, particularly in cases where continuous infusion is required.

Elastomeric Infusion Pump Market Key Drivers

Some of the key factors driving the market for elastomeric infusion pumps include:

  • Advancements in technology: The event of advanced elastomeric infusion pumps with features like flow control, occlusion alarms, and anti-siphon valves is driving the demand for these devices. Additionally, the event of smart pumps with wireless connectivity and remote monitoring capabilities is further boosting the market growth.
  • Growing aging population: Because the population ages, the prevalence of chronic conditions like diabetes and heart condition is predicted to extend. These conditions often require long-term treatment with medications, which may be administered using elastomeric infusion pumps.
  • Cost-effectiveness: Elastomeric infusion pumps are often less costly than other sorts of infusion pumps, making them a beautiful option for healthcare providers and patients. Additionally, they will be easily disposed of after use, reducing the necessity for cleaning and maintenance.
  • Growing demand for home healthcare: There's a growing demand for home healthcare services, and this is often expected to drive the marketplace for elastomeric infusion pumps. As more patients receive treatment reception, the necessity for reliable, portable infusion pumps will increase.
  • Increasing adoption in medicine: The utilization of elastomeric infusion pumps isn't limited to human medicine but is additionally gaining popularity in veterinary medicine. this is often driving the demand for these devices within the veterinary market.
  • Increasing healthcare spending: As healthcare spending increases globally, the marketplace for elastomeric infusion pumps is predicted to grow. this is often because governments and insurance companies are willing to take a position in medical devices that will improve patient outcomes and reduce healthcare costs.
  • Increasing prevalence of chronic diseases: The growing incidence of chronic diseases like cancer, diabetes, and cardiovascular diseases is driving the demand for long-term intravenous therapy, which may be delivered more conveniently and cost-effectively through elastomeric infusion pumps.

Elastomeric Infusion Pump Market Segmentation

The elastomeric infusion pump market can be segmented based on several factors, including:

  • By Type Of Pump
    • Peristaltic pumps
    • Diaphragm pumps
    • Piston pumps
  • By Application Type
    • Pain management
    • Chemotherapy
    • Antibiotics
  • By End-User
    • Hospitals
    • Clinics
    • Home Healthcare Settings
  • By Product Type
    • Disposable
    • Reusable
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa

Elastomeric Infusion Pump Market Regional Synopsis

The North American region dominates the elastomeric infusion pump market due to factors like the increasing prevalence of chronic diseases, well-established healthcare infrastructure, and high adoption of technologically advanced medical devices. The CAGR for the North American market is predicted to be around 7.2% from 2022 to 2028. The market size in 2021 was valued at approximately $373 million. Europe is the second-largest marketplace for elastomeric infusion pumps thanks to the presence of an outsized geriatric population and therefore the increasing prevalence of chronic diseases. The market is predicted to witness steady growth with a CAGR of roughly 6.5% from 2022 to 2028. The market size in 2021 was valued at around $270 million.

The Asia-Pacific region is predicted to be the fastest-growing marketplace for elastomeric infusion pumps thanks to the increasing demand for cost-effective medical devices, the rising geriatric population, and therefore the improving healthcare infrastructure. Countries like China and India are expected to contribute significantly to plug growth. The region is predicted to witness the very best CAGR with a rate of roughly 8.4% from 2022 to 2028. The market size in 2021 was valued at approximately $129 million.

The Latin American region is predicted to witness moderate growth within the elastomeric infusion pump market thanks to the increasing incidence of chronic diseases and rising demand for home healthcare services. The region is predicted to witness moderate growth with a CAGR of roughly 5.9% from 2022 to 2028. The market size in 2021 was valued at around $54 million.

The Middle East & African region is expected to witness moderate growth in the elastomeric infusion pump market due to the increasing investment in healthcare infrastructure and rising awareness about the benefits of elastomeric infusion pumps. The market is predicted to witness steady growth with a CAGR of roughly 6.7% from 2022 to 2028. The market size in 2021 was valued at approximately $25 million.


Elastomeric Infusion Pump Market Key Challenges

Some of the challenges facing the elastomeric infusion pump market include:

  • Competition from alternative devices: The elastomeric infusion pump market is facing competition from alternative devices like syringe pumps and intravenous (IV) pumps. These devices may offer advantages in certain situations, and healthcare providers may prefer to use them rather than elastomeric infusion pumps.
  • The complexity of use: Some elastomeric infusion pumps are often complex to use, which may cause errors and accidents. this will be especially challenging in home healthcare settings, where patients or caregivers might not have received proper training on the way to use the pumps.
  • High cost: Elastomeric infusion pumps are often expensive, which may make them out of reach for a few patients or healthcare providers. this will be a barrier to adoption, especially in developing countries where healthcare budgets are often limited.
  • Limited volume and dose control: Elastomeric infusion pumps aren't suitable for delivering precise or high-volume doses of medication. this will be a limitation for patients who require highly individualized or precise dosing.
  • Regulatory issues: Regulatory issues and therefore the need for compliance with safety and quality standards are often a challenge for manufacturers of elastomeric infusion pumps. the necessity for pre-market approval from regulatory agencies like the FDA also can hamper the market entry of the latest products.
  • Risk of infection: there's a risk of infection related to elastomeric infusion pumps because the pumps can become contaminated with bacteria if they're not properly cleaned and sterilized. this will be a priority for patients, especially those with compromised immune systems.
  • Technical limitations: Elastomeric infusion pumps have technical limitations which will impact their reliability and accuracy, like variability in pressure and flow.

Elastomeric Infusion Pump Market Key Players

Some key players in the elastomeric infusion pump market include:

  • B. Braun Melsungen AG: B. Braun is a global healthcare company based in Germany that manufactures a variety of medical products, including elastomeric infusion pumps.
  • Baxter International Inc.: Baxter International is a global healthcare company that develops and manufactures medical devices, pharmaceuticals, and biotechnology products. The company's infusion pump portfolio includes the Infusor and SIGMA Spectrum pumps.
  • BD (Becton, Dickinson, and Company): BD is a global medical technology company based in the USA that gives a variety of elastomeric infusion pumps for various applications.
  • Fresenius Kabi AG: Fresenius Kabi may be a leading global healthcare company that focuses on the event and manufacturing of medical devices and pharmaceutical products. The company's infusion pump portfolio includes the Volumat Agilia and Infusomat Space pumps.
  • Halyard Health, Inc.: Halyard Health is a medical technology company that gives a variety of healthcare products and solutions, including infusion pumps. The company's Elastomeric Infusion Pump is meant for the continuous delivery of medication throughout your time.
  • Smiths Medical, Inc.: Smiths Medical is a leading global manufacturer of medical devices and equipment. The company's infusion pump portfolio includes the CADD-Legacy PCA pump and therefore the CADD-Prizm PCS II pump.
  • Terumo Corporation: Terumo is a Japanese company that manufactures and sells a variety of medical products, including elastomeric infusion pumps.


Need Customized Report for Your Business ?

Utilize the Power of Customized Research Aligned with Your Business Goals

Request for Customized Report
Get 10% discount on any market research report of your choice.
Booklet
  • Publication date: 27th December 2023
  • Base year: 2022
  • Forecast year: 2023-2033
  • Format: PDF, PPT,Word,Excel

- ISO Certified Logo -


Frequently Asked Questions(FAQ)

An elastomeric infusion pump may be a device that's wont to deliver a selected amount of medication or fluid to a patient over a group period of your time. These pumps are commonly utilized in hospitals, clinics, and residential healthcare settings, and are often wont to administer medications like pain management drugs, antibiotics, and chemotherapy agents.

A number of the key drivers of the elastomeric infusion pump market include an aging population, increasing prevalence of chronic diseases, growing demand for home healthcare services, and advances in technology.

Some key players within the elastomeric infusion pump market include B. Braun Melsungen AG, Fresenius Kabi, Terumo Corporation, BD (Becton, Dickinson, and Company), and Smiths Medical.

A number of the most challenges facing the elastomeric infusion pump market include high costs, the complexity of use, the risk of infection, competition from alternative devices, and regulatory challenges.

The regions for the elastomeric infusion pump market are expected to be Asia-Pacific, North America, Europe, Latin America, and therefore the Middle East and Africa.

The worldwide elastomeric infusion pump market was valued at $610.8 million in 2022 and is predicted to succeed at $1.0 billion by 2032, growing at a CAGR of 5.2% during the forecast period of 2023-2032

-: Our Clients :-

Subscribe to Our Company Updates

* We will not share your personal information with anyone
Go Up